May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Drug Delivery Across the Cornea by PEGylated Liposomes in vitro and in vivo
Author Affiliations & Notes
  • D. Tang
    University of Louisville, Louisville, KY
    Ophthalmology and Visual Sci,
  • S. Xiao
    University of Louisville, Louisville, KY
    Ophthalmology and Visual Sci,
  • J.M. Donaldson
    University of Louisville, Louisville, KY
    Medical School,
  • D. Borchman
    University of Louisville, Louisville, KY
    Ophthalmology and Visual Sci,
  • Footnotes
    Commercial Relationships  D. Tang, None; S. Xiao, None; J.M. Donaldson, None; D. Borchman, None.
  • Footnotes
    Support  Alcon Research Limited (Fort Worth, TX) and Kentucky Lions Eye Foundation (Louisville, KY)
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5100. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D. Tang, S. Xiao, J.M. Donaldson, D. Borchman; Drug Delivery Across the Cornea by PEGylated Liposomes in vitro and in vivo . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5100.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Our purpose was to design PEGylated liposomes to deliver drugs across the cornea which represents the greatest barrier for drug penetration into the anterior chamber.

Methods: : Liposomes were composed of DOTAP/DOPE/DOPE–PEG750 (1/1/0.025, mol/mol/mol) and CHEMS/DOPE/DOPE–PEG750 (1/1/0.025, mol/mol/mol). New Zealand rabbits were used. Liposomes were prepared by five freeze–thaw cycles, followed by 10 extrusions through membranes with a100 nm pore size. The fluorophore 8–aminonaphthalene–1,3,6–trisulfonic acid, disodium salt (ANTS) was trapped in the liposomes as a drug model so that delivery could be quantified. Free ANTS was removed by a Sephadex G–50 chromatography column and selected fractions were purified using a spin column. The same concentration of ANTS–PBS solution was used as control. Drug permeation through the cornea in vitro was conducted by using freshly enucleated eyeballs onto which the end of an 8 mm–diameter tube was sealed onto the cornea with Newskin liquid bandage (Medtech, Jackson, WY). The liposomes containing ANTS and control ANTS–PBS solution were applied respectively to the cornea through the open end of the tube. Drug permeation through the cornea in vivo was conducted by applying of the liposomes and control solutions to the rabbit's conjunctival sac of left and right eyes, respectively.

Results: : Data from in vitro experiments show that the amount of ANTS delivered to the aqueous humor is 1.35 (n=6) and 2.15 (n=12) fold higher for solutions containing DOTAP/DOTAP/DOPE–PEG750 liposomes and CHEMS/DOPE/PEG750 liposomes, respectively, compared with controls that did not contain liposomes. Data from in vivo experiments show that the amount of ANTS delivered to the aqueous humor by DOTAP/DOPE/DOPE–PEG750 liposomes is 1.62 (n=3) and 10.06 (n=3) fold higher than controls, whereas CHEMS/DOPE/DOPE–PEG750 liposomes is 1.21 (n=3) and 1.25 (n=3) fold higher than controls.

Conclusions: : Both PEGylated DOTAP and CHEMS containing liposomes increase drug penetration through the cornea. In future studies we propose to maximize drug delivery efficacy by adjusting the composition of the liposomes.

Keywords: cornea: epithelium • anterior chamber • lipids 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×